Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany marked ‘World Diabetes Day 2019’ by building diabetes care capacity in Africa and Asia.
Dr. Rasha Kelej, CEO of Merck Foundation explained, “We strongly believe that starting the “Merck Nationwide Diabetes Blue Points Project” is the right strategy to ensure that every provenance in Africa will have the diabetes care they deserve and not only the capital or main cities. In partnership with African First Ladies and Ministries of Health we are trying to provide one year on line diploma for doctors from different provinces, counties or districts of respective countries, ensuring geographical coverage of the whole country. The aim is to build a platform of diabetes experts nationwide across Africa. It is a very difficult Diploma; it needs dedication and hard work therefore selection and screening of the right candidates is the key to ensure their continuity and success but Ministries of Health are doing great job to find the eligible candidates who do not drop out of the course.”
Merck Foundation is providing for One-Year Diploma in Diabetes Management and Preventive Cardiovascular Medicine from University of South Wales, UK.
Moreover, Merck Foundation is providing for French Speaking countries the ‘Master course in the Clinical Management of Diabetes’ in French, accredited by the Royal College of General Practitioners, United Kingdom.
So far, Merck Foundation has already enrolled more than 180 candidates under their ‘Merck Nationwide Diabetes Blue Point Project’ from 34 African and Asian Countries including Bangladesh, Botswana, Burkina Faso, Burundi, Cambodia, Cameroon, Central African Republic, Chad, Democratic Republic of Congo, Ethiopia, Gabon, Ghana, Indonesia, Kenya, Liberia, Malaysia, Mauritius, Myanmar, Namibia, Nepal, Niger, Nigeria, Philippines, Rwanda, Senegal, Sierra Leone, South Africa, Sri Lanka, Tanzania, Gambia, UAE, Uganda, Zambia and Zimbabwe.
“On completion of course, clinicians will setup diabetes clinic within public sector setting, nationwide. This will mark another milestone of our commitment to working with governments, academia and relevant stakeholders in building healthcare capacity with a focus on non-communicable diseases in developing countries” added Dr. Rasha Kelej.
Lorato Wadikonyana from Botswana, candidate enrolled under Diabetes Blue Points Project says, “This course will be very beneficial not only for me but also for the people of my country as it will enable me to provide them right care and treatment for the complications that arise due to diabetes”.
George Mshanga from Zambia, candidate enrolled under Diabetes Blue Points Project says “I am delighted to be a beneficiary of this project, as it this will enable me to improve my knowledge and experience and utilize my expertise to help and treat the people of my country.”
Distributed by APO Group on behalf of Merck Foundation.
Join the conversation on our social media platforms below and let your voice be heard:
About Merck Foundation:
The Merck Foundation (www.Merck-Foundation.com), established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.Merck-Foundation.com to read more. To know more, reach out to our social media: Merck Foundation (www.Merck-Foundation.com), Facebook (https://bit.ly/2pgsyMk), Twitter (https://bit.ly/350heDd), Instagram (https://bit.ly/2ObxTgp) YouTube (https://bit.ly/2CKvHY1) and Flicker (https://bit.ly/2KAD3ll).
Merck (www.MerckGroup.com) is a leading science and technology company in healthcare, life science and performance materials. Almost 53,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.
Dr. Rasha Kelej, CEO Merck Foundation with H.E. CLAR MARIE WEAH, The First Lady of Liberia and H.E. PROF. GERTRUDE MUTHARIKA, The First Lady of Malawi